Survival behavior of patients treated with curative and palliative electrochemotherapy for oral and oropharyngeal cancer: a systematic review
- 23 November 2025
- journal article
- review article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (5) , 2665-2680
Abstract
Objective The primary objective of this review is to assess the survival outcomes of patients affected by oral cavity and oropharyngeal squamous cell carcinoma (SCC) treated with electrochemotherapy (ECT). Secondarily, the authors aim to quantify these outcomes according to treatment intent (curative versus palliative) and to evaluate potential prognostic factors influencing survival. Methods A systematic literature review was conducted in accordance with the PRISMA 2020 guidelines. A comprehensive search was carried out in Embase, PubMed, Scopus, and the Cochrane Library databases to identify studies published between January 1998 and April 2025. Results Sixteen studies comprising a total of 120 patients were analysed. Overall, ECT was generally well tolerated, with acceptable and manageable adverse events. In the curative-intent cohort, a complete response was achieved in 74% of cases, with a recurrence rate of 12%. One- and two-year disease-free survival (DFS) rates were 94.8% and 77.5%, respectively. Prognostic factors associated with improved survival included early tumor stage, use of adjuvant therapy, and tumors located in the anterior oral cavity. In the palliative-intent cohort, a partial or complete response was observed in 74% of patients, with a one-year DFS of 29.3%. Negative prognostic factors included recurrent disease, prior treatments, and the presence of distant metastases. Conclusions ECT appears to be a promising therapeutic strategy for selected patients with oral cavity and oropharyngeal SCC, particularly in early-stage, treatment-naïve cases. Accurate prognostic stratification is essential to optimize patient selection and improve clinical outcomes.Keywords
This publication has 38 references indexed in Scilit:
- Challenges in pathological diagnosis of rare head and neck cancers: National survey and retrospective studyEuropean Archives of Oto-Rhino-Laryngology, 2025
- Features related to temporary tracheotomy in patients undergoing Transoral Robotic Surgery (TORS) for supraglottic squamous cell cancer of the larynx: A systematic reviewAmerican Journal of Otolaryngology, 2024
- Electrochemotherapy (ECT) in treatment of mucosal head and neck tumors. An international network for sharing practices on ECT (InspECT) study group reportEuropean Journal of Surgical Oncology, 2024
- Response to Electrochemotherapy in a Patient With Advanced Oropharyngeal Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2020
- Survival outcomes after treatment of cancer of the oral cavity (1985–2015)Oral Oncology, 2019
- The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancerHead & Neck, 2018
- European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancersEuropean Journal of Cancer, 2017
- Treatment Factors Associated With Survival in Early-Stage Oral Cavity CancerJAMA Otolaryngology–Head & Neck Surgery, 2015
- Electrochemotherapy in non-melanoma head and neck cancers: a retrospective analysis of the treated casesBritish Journal of Oral and Maxillofacial Surgery, 2014
- Ergebnisse aus dem DÖSAK-TumorregisterMund-,Kiefer- und Gesichtschirurgie, 2000